Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marine Boudot de la Motte

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Therapeutic Advances in Neurological Disorders|June 25, 2026
Cladribine use for multiple sclerosis with autoimmune comorbidities: retrospective analysis of the French MS registry, case series, and therapeutic considerationsVito A G Ricigliano, Ines Masmoudi, Marine Boudot de la Motte, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Extensive white matter lesions after 2 years of fingolimod: Progressive multifocal leukoencephalopathy or MS relapse?Marine Boudot de la Motte, Céline Louapre, Anne Bertrand, et al.
Journal of Neuroimmunology|September 13, 2021
IgG4-related pachymeningitis and mastoiditis, associated with cerebral venous thrombosis: A case reportChristelle Nilles, Guillaume Poillon, Lydia Deschamps, et al.
Journal of the Neurological Sciences|May 21, 2023
Natalizumab extended-interval dosing in a real-life settingLina Jeantin, Marine Boudot de la Motte, Romain Deschamps, et al.
Multiple Sclerosis and Related Disorders|May 18, 2021
Challenges of switching towards anti-CD20 monoclonal antibodies in RR-MS: A monocentric studyMarine Boudot de la Motte, Céline Louapre, Caroline Papeix, et al.
Clinical Medicine (London, England)|April 8, 2018
Systemic inflammatory disorders in patients admitted for aseptic meningitisMarine Boudot de la Motte, Rachid Abbas, Fanny Jouan, et al.
Diagnostic and Interventional Imaging|September 6, 2024
Comparison between contrast-enhanced fat-suppressed 3D FLAIR brain MR images and T2-weighted orbital MR images at 3 Tesla for the diagnosis of acute optic neuritisSharmiladevi Manasse, Patricia Koskas, Julien Savatovsky, et al.
AJNR. American Journal of Neuroradiology|June 20, 2024
Comparison of a Whole-Brain Contrast-Enhanced 3D TSE T1WI versus Orbits Contrast-Enhanced 2D Coronal T1WI at 3T MRI for the Detection of Optic Nerve Enhancement in Patients with Acute Loss of Visual AcuityDavid Prillard, Frédérique Charbonneau, Pierre Clavel, et al.
European Journal of Neurology|February 20, 2025
Long-Term Outcome and Prognosis of Idiopathic Optic Neuritis: A Cohort StudyBenjamin Leger, Antoine Gueguen, Augustin Lecler, et al.
Journal of Neurology|April 20, 2026
Optic chiasmal neuritis: clinical features, aetiologies, MRI patterns and prognosis in a real-world cohortVincent Brochard, Augustin Lecler, Edouard Januel, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Therapeutic Advances in Neurological Disorders|June 25, 2026
Cladribine use for multiple sclerosis with autoimmune comorbidities: retrospective analysis of the French MS registry, case series, and therapeutic considerationsVito A G Ricigliano, Ines Masmoudi, Marine Boudot de la Motte, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 10, 2017
Extensive white matter lesions after 2 years of fingolimod: Progressive multifocal leukoencephalopathy or MS relapse?Marine Boudot de la Motte, Céline Louapre, Anne Bertrand, et al.
Journal of Neuroimmunology|September 13, 2021
IgG4-related pachymeningitis and mastoiditis, associated with cerebral venous thrombosis: A case reportChristelle Nilles, Guillaume Poillon, Lydia Deschamps, et al.
Journal of the Neurological Sciences|May 21, 2023
Natalizumab extended-interval dosing in a real-life settingLina Jeantin, Marine Boudot de la Motte, Romain Deschamps, et al.
Multiple Sclerosis and Related Disorders|May 18, 2021
Challenges of switching towards anti-CD20 monoclonal antibodies in RR-MS: A monocentric studyMarine Boudot de la Motte, Céline Louapre, Caroline Papeix, et al.
Clinical Medicine (London, England)|April 8, 2018
Systemic inflammatory disorders in patients admitted for aseptic meningitisMarine Boudot de la Motte, Rachid Abbas, Fanny Jouan, et al.
Diagnostic and Interventional Imaging|September 6, 2024
Comparison between contrast-enhanced fat-suppressed 3D FLAIR brain MR images and T2-weighted orbital MR images at 3 Tesla for the diagnosis of acute optic neuritisSharmiladevi Manasse, Patricia Koskas, Julien Savatovsky, et al.
AJNR. American Journal of Neuroradiology|June 20, 2024
Comparison of a Whole-Brain Contrast-Enhanced 3D TSE T1WI versus Orbits Contrast-Enhanced 2D Coronal T1WI at 3T MRI for the Detection of Optic Nerve Enhancement in Patients with Acute Loss of Visual AcuityDavid Prillard, Frédérique Charbonneau, Pierre Clavel, et al.
European Journal of Neurology|February 20, 2025
Long-Term Outcome and Prognosis of Idiopathic Optic Neuritis: A Cohort StudyBenjamin Leger, Antoine Gueguen, Augustin Lecler, et al.
Journal of Neurology|April 20, 2026
Optic chiasmal neuritis: clinical features, aetiologies, MRI patterns and prognosis in a real-world cohortVincent Brochard, Augustin Lecler, Edouard Januel, et al.
Pageof 3